ANTAGONISTIC REGULATION OF SMC CONTRACTION
At the molecular level, airway SMC contraction is fundamentally regulated by the antagonistic activities of myosin light-chain (MLC) kinase (MLCK) and MLC phosphatase (MLCP) ( Figure  1 ). The net activity of these enzymes determines the phosphorylation state and, thereby, the activity of the regulatory MLC (rMLC). This, in turn, determines the extent of actin-myosin cross-bridge interactions and force production. The regulation of MLCK activity is generally believed to be a function of the [Ca 21 ] i , although MLCK activity can also be increased by Ca 21 -independent processes. By contrast, the regulation of MLCP activity has generally been considered independent of [Ca 21 ] i , but is determined by the complex interactions and activities of a variety of other kinases or phosphatases. This separation of the regulatory mechanisms of MLCP activity from the Ca 21 regulation of MLCK means that changes in SMC contraction can occur independently of changes in Ca 21 concentration, and this has been referred to as Ca 21 sensitivity. However, a broader definition of Ca 21 sensitivity is required, because changes in the contractile force at similar Ca 21 concentrations can also occur by mechanisms that do not alter the phosphorylation of the rMLC. Because both the Ca 21 signaling and Ca 21 sensitivity of SMCs are receptor-mediated processes, an alteration of SMC tone in disease may occur by either or both mechanisms in response to a variety of putative or inflammatory signaling molecules (Figure 1) . Consequently, the relative contribution and mechanisms of the Ca 21 signaling and Ca 21 sensitivity of SMCs must be understood in detail.
Ca 2+ OSCILLATIONS
Although it has been established that SMC contraction usually requires an increase in [Ca 21 ] i , our understanding of the nature of this Ca 21 increase has improved with time. Initially, agonistinduced Ca 21 increases were observed to occur as a whole-cell transient in Ca 21 followed by a lower, sustained plateau of Ca 21 . However, more recently, with higher resolution microscopy, these Ca 21 increases have been observed to occur as a series of Ca 21 oscillations in airway SMCs of many species, including mouse, pig, and human (7) (8) (9) (10) (11) . In addition, these Ca 21 oscillations have dynamic spatial characteristics, and commonly occur as Ca 21 waves that propagate along the full length of the SMCs. Interestingly, the origination site of the Ca 21 oscillations is often localized to one end of the cell. Ca 21 oscillations have also been frequently observed in systemic blood vessels (8) , and we have observed them in intrapulmonary arterioles (9) . Importantly, the increasing frequency of these Ca 21 oscillations correlates with an increasing agonist concentration and SMC contraction, but the amplitude of the Ca 21 oscillations generally remains similar.
In airway and vascular SMCs, agonists initiate, but cannot maintain, contraction in Ca 21 -free conditions. This response correlates with the initiation, but subsequent run-down, of the Ca 21 oscillations, and indicates that Ca 21 oscillations are mediated by repetitive release of Ca 21 from internal stores that require refilling by Ca 21 influx (7, (10) (11) (12) . The mechanisms by which Ca 21 is repetitively released appear to vary between SMCs of different species or from different locations within the airway. However, by understanding and reconciling these variations, the importance of changes in this form of signaling can be evaluated in disease. There are two basic release mechanisms, centered on either the inositol trisphosphate (IP 3 ) receptor (IP 3 R) or the ryanodine receptor (RyR) with Ca 21 21 ] may also be critical for the regulation of the SR release channel.
In the above scenario, it is implied that the IP 3 concentration is stable. However, in some cells, the activity of phospholipase C(PLC), the enzyme that generates IP 3 , is Ca 21 sensitive. Consequently, the IP 3 concentration may also oscillate along with the changes in Ca 21 to perpetuate the Ca 21 oscillations. The feedback mechanisms driving Ca 21 oscillations can be distinguished by examining the effect of the fast release (by photolysis) of a bolus of IP 3 (17) . In cells displaying Ca 21 oscillations, an increase in IP 3 is predicted to increase the frequency of the Ca 21 oscillations that rely on the dynamics of Ca 21 inhibition of the IP 3 R, but to delay the onset of the next Ca 21 oscillation that relies on the dynamics of the IP 3 concentration. In airway SMCs, the release of IP 3 increased the frequency of the Ca 21 oscillations, and this implies that these oscillations occur by Ca 21 feedback dynamics. This is also consistent with the fact that the frequency of Ca 21 oscillations mediated by Ca 1 -induced IP 3 production (found in pancreatic cells) are relatively slow (1/min) compared with those of airway SMCs (20/min; induced by ACh) (17) . Further evidence for Ca 21 oscillations mediated by IP 3 comes from the findings that the photolytic release of IP 3 in airway SMCs, in the absence of agonist, induces both Ca 21 oscillations and contraction. In addition, agonist-induced Ca 21 oscillations in SMCs of lung slices persist in the presence of ryanodine (18) , and are inhibited by 2-aminoethoxydiphenyl borate (2-APB), an antagonist of the IP 3 R.
RyR-BASED MECHANISMS
In an alternative scheme, Ca 21 oscillations are proposed to be mainly mediated by CICR via the RyR. This idea was proposed because ACh-induced Ca 21 oscillations in isolated porcine tracheal SMCs were found to be slowed by ryanodine and inhibited by caffeine, both RyR antagonists (11) . A subsequent study with permeabilized cells indicated that sustained Ca 21 increases could be induced by IP 3 and that ACh-induced Ca 21 oscillations were slowed by heparin, an IP 3 R antagonist. However, the same AChinduced Ca 21 oscillations were abolished by ryanodine and ruthenium red (19) , another RyR antagonist. Consequently, although there appears to be a requirement for IP 3 in the initiation of the Ca 21 oscillations, the maintenance of the Ca 21 oscillations appears to require the RyR (19) . A similar inhibition of ACh- induced Ca 21 oscillations by ryanodine was found in muscle bundles from porcine or human airways (12, 20) . Carbachol-induced contraction of mouse tracheal rings was also decreased by ryanodine, but the role of Ca 21 oscillations was not addressed (21) . Although ryanodine inhibits RyR activity, it may also serve to empty the internal Ca 21 stores and thereby affect the IP 3 -induced Ca 21 oscillations. Other inhibitors of the RyR, such as procaine and tetracaine, also stopped the Ca 21 oscillations, but the use of these compounds on whole cells is not compelling, due to their nonspecific actions. A role for IP 3 R-based Ca 21 oscillations in airway SMCs was argued against by the failure of 2-APB and xestospongin-C (IP 3 R antagonists) to inhibit the Ca 21 oscillations, especially because 2-APB inhibited phenylephrine-induced Ca 21 oscillations in SMCs of the vena cava (22) . In view of these data and those examining the role of the IP 3 R, it is perplexing that the results of very similar experiments are contrary. In many other cell types, Ca 21 oscillations are thought to occur via the IP 3 R; therefore, it is essential to understand these differences to fully explain Ca 21 oscillations in airway SMCs. 21 oscillations. In these cells, IP 3 was also found to release Ca 21 , but did not induce Ca 21 oscillations. However, this is consistent with the facts that the concentration of IP 3 used was relatively high and that high concentrations of IP 3 generally induced plateaus in Ca 21 concentrations rather than Ca 21 oscillations. An action for cADPr was also found in isolated equine SMCs, where it increased the frequency of spontaneous transient inward currents (usually an indicator of Ca 21 sparks). This response was both mimicked and antagonized by tacrolimus (or FK506, a compound that binds RyR-associated proteins, FK binding protein [FKBP] ) and lost in FKBP12.6 null ( 2/2 ) mice (24) . The response to FK506 was insensitive to heparin, but was abolished by ruthenium red, which implicates the RyR. However, ACh still evoked Ca 21 changes in the presence of ruthenium red, suggesting that the IP 3 signaling pathway remained viable. The effects of FK506 appeared to be mediated through the RyR 2 , because the RyR 1 and RyR 3 were not abundant (24) , although all three RyRs have been shown to be expressed in mouse SMCs (21) . In summary, the above studies indicate that ACh-induced Ca 21 changes or oscillations may require both IP 3 and cADPr. The IP 3 R may initiate the Ca 21 oscillations and determine their baseline characteristics, but, in the presence of cADPr, the RyR may amplify or modify the dynamics of the Ca 21 response.
CYCLIC ADENOSINE DIPHOSPHATE RIBOSE AS A SECOND MESSENGER
The possible involvement of cADPr in Ca 21 release of airway SMCs has stimulated a number of studies investigating the relationship between cADPr, its synthesis by the ectoenzyme, CD38, and AHR (25) (26) (27) . The enzymes necessary for the conversion of nicotinamide adenine dinucleotide to cADPr (mainly, CD38) were found to be present on the membranes of airway SMCs (28) . Moreover, the activity and quantity of this enzyme appears to be upregulated by a variety of cytokines that are associated with inflammation (29) (30) (31) . In cultured human airway SMCs, tumor necrosis factor-a, IL-1b, and IFN-g increased CD38 expression and ADP-ribosyl cyclase activity. Similarly, IL-13 increased CD38 expression (30) . In addition, extracellular cADPr (28) and a variety of cytokines (29, 30, 32, 33) have been reported to augment Ca 21 signals and contraction of airway SMCs. However, the effect of these treatments on the Ca 21 signaling is not easily interpreted. Although the transient peak response or net response (peak 2 baseline) to a variety of agonists (ACh, bradykinin, thrombin, histamine) was increased, the sustained response to the agonists appeared similar (29, 30) . In these studies, it is not clear if the SMCs displayed Ca 21 oscillations, but the net increases appeared to be attenuated by 8-bromo-cADPr. In view of the more recent data that indicate that contraction is related to the sustained frequency of the Ca 21 oscillations, the relevance of the net change is unclear.
The idea that cytokines can alter airway responsiveness via CD38 expression has been further supported by studies with CD38-deficient mice (26, 34) . In CD38 2/2 mice, the airway resistance and lung compliance in responses to methacholine (MCh) was reported to be lower than the changes invoked in control mice. These attenuated whole-lung response correlated with a net or integrated decrease in the Ca 21 responses of isolated tracheal SMCs to ACh or endothelin (ET). Although the SMCs displayed Ca 21 oscillations in response to ACh and ET, it was reported that there was no difference in the oscillatory behavior between the control and CD38 2/2 mice. In addition, the Ca 21 responses of the CD38 2/2 mice were unaffected by 8-bromo-cADPr. These responses suggested that cADPr production is either not required for, or modulates, ACh-induced Ca 21 oscillation in mice. On the other hand, cADPr did appear to influence the initial peak Ca 21 response, but, again, it is not clear how this transient Ca 21 response relates to sustained SMC contraction implied by changes in airway resistance measurements. The idea that cADPr contributes to airway responsiveness is also implicated in CD38 2/2 mice that are subjected to IL-13 exposure. In these mice, IL-13 did not induce the expected increase in sensitivity to MCh normally found in IL-13-exposed control mice, even though the lungs showed similar signs of inflammation (26) .
Another important requirement of a second messenger is its production in response to agonists. Consequently, the finding that cADPr levels in porcine SMCs were substantially increased within 1 minute of exposure to the contractile agonists, ACh, bradykinin, ET, and histamine, supports its role in regulating contraction (35) . Importantly, the increase in cADPr was sustained (at least for the periods of measurement: 5 min), although a proportional increase related to the concentration of the stimulating agonists or the receptor type was not clearly evident.
The above studies form a consensus that CD38 expression can be increased by inflammation and that this inflammation appears to augment SMC Ca 21 signaling in a cADPr-dependent manner; however, the details of these relationships are not clear. The studies have been conducted with human, porcine, and mouse tissues and isolated cells, and this gives rise to inconsistent results and makes the correlation of contraction and Ca 21 signaling difficult. Recently, two approaches for examining and correlating cell and tissue responses have been reported using either lung slices, which are compatible for mouse, rat, and hamster tissues, or tracheal strips, which are useful for large airway SMCs from porcine or human tissue. It is likely that, with these techniques, the inferences that cADPr acts via RyRs to modulate agonist-induced Ca 21 (38, 39) .
The idea that airway SMCs are relaxed by hyperpolarization implies that SMC contraction requires membrane depolarization and an associated Ca 21 influx, presumably via voltage-gated Ca 21 channels. In many studies, KCl has been used to depolarize and contract airway SMCs (40) . Because this response is abolished or reduced by the absence of extracellular Ca 21 or inhibitors of voltage-gated Ca 21 channels in isolated cells (11, 40) and lung slices (10), airway SMC contraction mediated by Ca 21 influx appears feasible.
On the other hand, the use of L-type channel blockers to treat AHR in asthma has been without success. Extensive reviews of this concept (6, 41) emphasize that the extent of depolarization of airway SMCs induced by agonists is inadequate to fully activate voltage-gated Ca 21 channels to exploit this signaling mechanism. In support of this viewpoint, airway SMCs display strong contraction in response to a wide variety of agonists that induce Ca 21 oscillations that are primarily dependent on intracellular Ca 21 release. Furthermore, this agonist-induced airway contraction is significantly larger and more stable than KCl-induced contraction in small airways of lung slices. The Ca 21 oscillations persist for multiple cycles in the absence of extracellular Ca 21 or in the presence of Ca 21 channels blockers (e.g., Ni 21 ) (10, 11, 42) . Similarly, agonist-induced contraction and/or Ca 21 oscillations were unaffected in lung slices (10) and isolated cells (43) , or only partially slowed in tracheal strips by L-type calcium channels blockers (20, 44) . The conclusion drawn from these data is that airway SMC contraction relies primarily on intracellular Ca 21 21 sparks followed by a period of quiescence has been observed in isolated tracheal cells (38) , and this type of behavior has been commonly observed in cardiac myocytes that are overloaded with Ca 21 .
Because we only observed Ca 21 sparks in intrapulmonary SMCs under conditions of KCl-induced stress (10) where it appeared that Ca 21 was leaking into the cell, we believe that the Ca 21 store becomes overfilled. This, in turn, leads to the progressive sensitization of the RyR channel, which is visualized by the increase in frequency of the elemental signaling events. When the Ca 21 store content is elevated, the heightened Ca 21 sensitivity of the RyR allows a single elemental event to ''spark'' a propagated Ca 21 wave via CICR and opening of RyR channels to empty the Ca 21 store. The reduced Ca 21 content of the store resets the system. This activity is similar to the observation that Ca 21 waves in isolated SMCs are initiated from areas of high Ca 21 spark activity (7, 38) . This sensitization hypothesis was further investigated by mimicking the occurrence of an elemental Ca 21 event with the release of caged Ca 21 . A pulse of Ca 21 was found to have little effect on cells under normal conditions. However, in the cells that were exposed to KCl, a similar Ca 21 release evoked a propagating Ca 21 wave (18) .
These data suggest that elemental Ca 21 signaling in airway SMCs occurs in response to store filling. Ca 21 leakage into the cell could be countered by Ca 21 uptake into the internal stores. Once these stores reach their capacity, the release of Ca 21 via Ca 21 sparks would serve both to stabilize the store Ca 21 concentration and minimize further Ca 21 influx by their action on Ca 21 -activated K 1 channels. In this sense, Ca 21 sparks would help prevent an uncontrolled increase in global Ca 21 to maintain a relaxed state in times of stress, but, under normal conditions, this process appears to be a secondary control for airway SMC contraction.
Although the physiological role for Ca 21 sparks in airway SMCs may be questioned, the value of studying elemental Ca 21 signaling with regard to determining receptor identification, participation and regulation in Ca 21 oscillations and propagated waves is unchallenged. Indeed, caution in naming the elemental Ca 21 signals in SMCs of lung slices arises from the fact that their duration was longer and their size was larger than that associated with Ca 21 sparks in other tissues (39) . However, the elemental Ca 21 
REFILLING OF Ca 2+ STORES BY Ca 2+ INFLUX
A common feature required to sustain agonist-induced contraction is the presence of extracellular Ca 21 ( Figure 1 ). However, voltage-dependent Ca 21 channels do not appear to strongly influence SMC contraction (6) . We found that agonist-induced contraction and Ca 21 oscillations of mouse bronchiole SMCs were unresponsive to L-type Ca 21 channel blockers (10) . On the other hand, nifedipine either inhibited (43, 46) or reduced the frequency of (12, 20) the Ca 21 oscillations of human or porcine and tracheal SMCs, respectively. A potential mechanism for membrane depolarization is the activation of an inward current mediated by Ca 21 -dependent Cl 2 channels as well as nonspecific cation currents (14, 47, 48) . However, changes in Cl 2 may have an additional electrogenic action to facilitate Ca 21 release and uptake across the SR (49) . Although these data indicate that there is a minor involvement of membrane depolarization and voltage-gated channels in refilling internal stores, the major conclusion is that additional mechanisms are employed for Ca 21 entry to maintain contraction.
A common mechanism believed to stimulate Ca 21 entry is the emptying of the internal stores to activate Ca 21 influx via membrane channels, called store-operated Ca 21 channels (SOCs) (50) . Many investigations have explored the proposed mechanism linking store depletion to influx, and recent studies have identified a potential Ca 21 sensor in the SR, stromal interacting molecule (STIM) 1, which may communicate with a cell membrane protein or channel (Orai1) (51, 52) . STIM1 is a protein that appears to have an SR luminal Ca 21 binding domain and, upon store emptying, the distribution of STIM1 changes from diffuse to form clusters adjacent to the plasma membrane. The linkage that STIM1 forms with the membrane channels is not entirely clear. The expression of STIM1 and its role in agonistinduced Ca 21 influx has been reported in human cultured airway SMCs (53) .
Although Ca 21 influx via SOCs appears to be a common mechanism, Ca 21 influx also occurs via receptor-operated channels (ROC) or second messenger operated channels. Of particular interest is the arachidonic acid-regulated Ca 21 channel (ARC), which, importantly, is activated without store depletion (54) . These channels are Ca 21 specific and are activated at low agonist levels, which are generally associated with Ca 21 oscillations in cells. Interestingly, STIM1 also appears to regulate ARC, but in a store-independent manner (55) . This raises the question as to which Ca 21 influx channels operate when, because store depletion is not thought to be extensive during Ca 21 oscillations. Ca 21 influx is further complicated by the potential role of the family of transient receptor potential channels (56) . This is a large family of channels that may form ROCs or SOCs, although they do not seem to be ARC channels. With the lack of reliable and specific agonists for many of these channels, their exact identity, distribution, and physiological role in Ca 21 influx remains the subject of ongoing research.
The opening of nonspecific cation channels can also lead to an increase in intracellular Na 1 near the cell membrane, and this is proposed to lead to the reversal of the Na 1 -Ca 21 exchanger to increase Ca 21 entry (20, 57) . Because the maintenance of Ca 21 oscillations and tone rely on Ca 21 influx, it is essential to understand these various pathways and their relationship to disease.
Ca 2+ SENSITIVITY OF SMCs
Although the mechanism underlying Ca 21 oscillations in airway SMCs is not fully resolved, there appears to be a consensus that SMCs frequency encode their Ca 21 signals to regulate contraction (10, 12, 58) . Despite the similarity of form and function of the Ca 21 oscillations, there are significant differences in the frequency-contractile relationship between different agonists, between airways and intrapulmonary arterioles (9, 10) , as well as between airway SMCs of different species (mouse and rat [18] ; swine and human [20] ) that need to be understood. For example, in the same airway, 5-HT produced slower oscillations than ACh, but induced greater contraction (10) . Similarly, 5-HT induced slower oscillations in pulmonary arteriole SMCs than in airway SMCs, but induced greater contraction in the arteriole SMCs (9) . We believe that a key component to understanding these differences in the frequency-contraction relationships is the Ca 21 sensitivity of the muscle (59) (Figure 1) .
Although the mechanisms of Ca 21 sensitivity in airway SMCs are not yet fully characterized (59, 60) , there have been many studies that indicate that increased Ca 21 sensitization most often reflects decreased MLCP activity (61) . Although a full review is beyond the scope of this article, there is evidence for two major pathways leading to decreased MLCP activity in airway SMCs. These are phosphorylation and inhibition of the regulatory myosin phosphatase target subunit (MYPT1) of MLCP by Rho kinase and phosphorylation of CPI-17, a 17-kD inhibitory protein of type 1 protein phosphatase, by protein kinase (PK) C. The production of Rho and diacylglycerol (DAG) to active Rho kinase and PKC are G-protein-coupled receptor processes, but depolarization by KCl also appears to sensitize cells to Ca 21 (62, 63) . Consequently, either the binding of agonist to the SMCs or the depolarization of the SMCs stimulates both an increase in MLCK activity via Ca 21 increases and a decrease in MLCP activity via secondary kinases.
In addition to changes in MLCP activity, changes in Ca 21 sensitization can also be mediated by modulating the phosphorylation of rMLC by Ca 21 -independent kinases (i.e., leucine zipper kinase) or by altering the myosin-actin cross-bridge interactions that generate force by actin-binding proteins (i.e., caldesmon).
To investigate the role of Ca 21 sensitivity in agonist-induced contraction, it is necessary to gain experimental control of the [Ca 21 ] i . This has commonly been achieved using either bacterial toxins or detergents to permeabilize the cell membrane (19, 23) . However, the disadvantage of these approaches is that the membrane integrity is compromised, and potentially important soluble cell components can be lost. To counter this problem, we have developed a lung slice ''model'' by simultaneously treating (64) . The result of this treatment is that the internal SR Ca 21 stores are emptied (indicated by no further Ca 21 increases in response to caffeine or agonists), which, in turn (as described previously here), activates a Ca 21 influx current mediated by SOCs. Because the effects of ryanodine are irreversible, the Ca 21 stores remain empty after the removal of caffeine/ryanodine, with the result that the cytosolic [Ca 21 ] i is a function of external [Ca 21 ]. In the lung slice, this allows the SMC [Ca 21 ] i to be clamped and correlated with airway contraction, and, because the cell membrane has not been disrupted, these ''model'' slices are viable for many hours.
Predictably, with this ''model'' lung slice, the arteriole SMCs contracted in response to a sustained increase in [Ca 21 ] i , but, surprisingly, the airway SMCs only transiently contracted and then relaxed (64) . Furthermore, the subsequent exposure of the slice to a contractile agonist (5-HT) induced a contraction of the airway (usually equal to that induced in a normal slice) and a further contraction of the arteriole without changing the [Ca 21 ] i in either SMC type. The result that mouse airway SMCs are relaxed by sustained high Ca 21 was not expected. In fact, it is likely that this result would be controversial if presented in isolation. However, one of the strengths of the lung slice preparation is that it provides the ability to perform experimental comparative physiology. Consequently, the simultaneous observation of different responses in the airway and arterioles in the same slice under the same conditions is compelling, and immediately emphasizes that the Ca 21 21 sensitivity. Consequently, in a normal SMC, the contractile response to an agonist results from a dose-dependent change in Ca 21 sensitivity and a dose-dependent change in the Ca 21 oscillation frequency. Similar conclusions were found with partial agonists of the muscarinic receptor (65) . This dual regulation of contraction helps explain why two different agonists can stimulate different levels of contractility at a similar Ca 21 oscillation frequency. Similar studies have revealed that rat airways have a greater sensitivity to Ca 21 than mouse airways; thus, species differences may also be explained. For us, these results have emphasized the importance of Ca 21 sensitivity in agonist-mediated Ca 21 signaling, and have convinced us that the contractile process must be examined from both viewpoints before it can be understood.
To explain Ca 21 -induced relaxation of airway SMCs, we have hypothesized that MLCP can be slowly activated by Ca 21 (64) . Thus, in response to a step increase in Ca 21 , the fasterresponding MLCK (via activation of Ca 21 /calmodulin) will initially induce phosphorylation of the rMLC to induce contraction. However, the slower but stronger activation of the MLCP by Ca 21 will dephosphorylate rMLC to counter the effects of MLCK and induce relaxation. The subsequent addition of agonist serves to inactivate MLCP by the process of Rho Kinase or PKC activation. Thus, the net MLCP activity is a balance between MLCP inactivation via Rho Kinase/PKC and activation via Ca 21 . Interestingly, our mathematical model of such a scheme confirms the feasibility of the hypothesis for airway SMCs, but, more importantly, it predicts the response of the arteriole, if the Ca 21 -dependence of the MLCP is omitted (66) .
RELAXATION OF AIRWAY SMCs
The objective of understanding SMC contraction is ultimately to understand how to relax airway SMCs and prevent asthmatic hyperresponsiveness. Clearly, from the rationale described previously here, SMC relaxation must result from either decreased [Ca 21 ] i or Ca 21 sensitization, or both (Figure 1 ). The mostly commonly used relaxant pathway in asthma control is mediated via increases in cAMP after the activation of adenylyl cyclase by b 2 -adrenergic agonists. Surprisingly, in view of the wide-spread use of these drugs, the action of cAMP is not fully defined, and may, in fact, have multiple effects. The most obvious way to induce relaxation would be the reversal of the Ca 21 increases. Because SMC Ca 21 increases were thought to result directly from Ca 21 influx, a focus on Ca 21 channels resulted. It was reported that the membrane hyperpolarization resulting from the activation of large-conductance, calcium-activated K (K Ca ) channels by increases in cAMP decreased Ca 21 influx (67-70), and antagonists of the K Ca channels (e.g., iberiotoxin) were reported to antagonize the effects of cAMP (71, 72) . Alternative ways to decrease [Ca 21 ] i include an inhibition of SOCs after Ca 21 store release (73) , an increase in SERCA pump activity (74, 75) , or an increase in Ca 21 efflux (76). However, because airway SMC contraction appears to use Ca 21 oscillations, we examined the effects of isoproterenol, forskolin, and cAMP analogs on airway SMCs in lung slices, and found that all these agents slowed the Ca 21 oscillation and induced relaxation. Similar decreases in Ca 21 oscillation frequency without contractile data were reported for isolated tracheal cells (67, 77) .
In view of the facts that the frequency of Ca 21 oscillations can depend on the refilling of Ca 21 stores, and that this refilling can be influenced by Ca 21 influx (13), it is possible that both of these mechanisms could contribute to a reduction of the Ca 21 oscillation frequency to induce relaxation. To test this idea, we increased the amount of Ca 21 available by flash photolysis of caged Ca 21 , increased the Ca 21 influx into the cell with ionomycin, or prevented a decrease in Ca 21 influx with iberiotoxin. Surprisingly, these treatments did not increase the frequency of the Ca 21 oscillations. By contrast, the oscillations either slowed or stopped and this enhanced the relaxing effects of cAMP rather than antagonizing them. These results suggest that Ca 21 availability for refilling stores was not a limiting factor. The similarity of the caffeine-induced Ca 21 release from internal stores in the presence or absence of forskolin also supports this idea.
Because the regulation of the Ca 21 oscillation frequency is also thought to be related to the sensitization of the IP 3 R, we examined the Ca 21 response to the photolysis of caged IP 3 . An increase in IP 3 was found to increase the frequency of Ca 21 oscillations slowed by exposure to forskolin, whereas, at threshold conditions, forskolin inhibited the ability of IP 3 to release Ca 21 . These results indicate that cAMP inhibits Ca 21 release from the IP 3 R in mice and rats (18) . A similar conclusion, that the action of relaxing agonists is focused more on the internal Ca 21 release processes rather than membrane hyperpolarization and Ca 21 influx via K Ca channels, was recently reached from studies with K Ca 2/2 mice (78). We have also found that nitric oxide (NO) strongly attenuates Ca 21 oscillations and relaxes airway and arteriole SMCs in mouse lung slices (79) . NO acts via guanylyl cyclase, the elevation of cGMP, and activation of cGMPdependent protein kinase type I (cGKI). NO-induced SMC relaxation appears to be mediated by decreasing [Ca 21 ] i by inhibiting the IP 3 R through the phosphorylation and complex formation with an IP 3 R-associated protein (IRAG) (80, 81) . This mechanism of action appears similar to the action of cAMP. However, a cAMP analog still relaxed SMCs from IRAG-or cGKI-deficient mice, a result implying that cAMP does not act on the IP 3 R via IRAG/cGKI. A slowing of Ca 21 oscillations was also induced by NO in isolated porcine tracheal cells (43) , but, because the Ca 21 oscillations in these cells seem to rely more on the RyR, it is not clear where NO (cGMP) acts.
The complementary mechanism by which cAMP/cGMP can act is by Ca 21 sensitization; cAMP-or cGMP-dependent kinases may alter the activity of MLCP or the proteins associated with contraction (72, 75, 82, 83) . Using the ''model'' lung slice, we have found that exposure to forskolin and a phosphodiesterase inhibitor (treatments that increase cAMP) relaxed airways by decreasing the Ca 21 sensitivity, as well as by reducing the Ca 21 oscillation frequency (64) . A similar finding has been concurrently reached with guinea pig trachea (82) .
TISSUE RESPONSES INFLUENCING CONTRACTILITY
For the most part, we have considered chemical regulators of contraction. However, mechanical influences appear to have a strong influence on airway SMC tone (Figure 1) . In normal lungs, inspiration can protect against airway constriction induced by MCh, whereas, in individuals with asthma, this response is attenuated (84) (85) (86) (87) . The mechanism underlying this response is poorly understood, but it has been proposed that dynamic stretching plasticizes the SMC cytosol to reduce its stiffness so that breathing forces can dilate the airways. It is not clear how traditional second messengers, such as Ca 21 , would influence the process. On the other hand, the fact that the stretchrelaxation response is lost in patients with asthma suggests that some pathophysiological process is acting on a key parameter. Acute stretch-induced responses mediated by the opening of ion channels to induce Ca 21 influx or activate Rho kinase (88, 89) would appear counterproductive to inducing airway relaxation. An alternative way in which stretch might reduce the Ca 21 sensitivity of the SMCs would be the release of NO by epithelial cells. However, the degree of Ca 21 sensitization may be adapted over a longer term or genetically encoded, as different strains of mice have been found to respond differently to mechanical ventilation (90) . In view of this, it is interesting that different mouse strains also showed different contractile responses to the same Ca 21 oscillation frequency (91) . This implies that different mouse strains have an inherently different level of Ca 21 sensitization, and we have emphasized that this concept seems to apply to a variety of species and agonists.
In summary, the aim of this research is to provide a basic understanding of the Ca 21 -based regulatory mechanisms of SMC contractility to identify the changes that mediate SMC hyperresponsiveness in asthma. The recognition that the control of airway SMC contraction is dynamic and relies strongly on internal Ca 21 release mechanisms and a simultaneous Ca 21 sensitization emphasizes the importance of the dual investigation of these process in response to disease conditions, such as airway inflammation.
Conflict of Interest Statement: M.J.S. is the recipient of research grants of $128,000 in 2006 and $125,000 in 2007 from Sepracor. P.D. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. Y.B. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. J.F.P.-Z. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript.
